Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027627 (
metastases
)
103,950
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Laboratory data indicate that colchicine has an antimetastatic effect in tissue culture and in tumor-transplantation experiments in animals. The present case report reveals a lack of perineural and capsular invasion as well as distant
metastases
from a large
adenocarcinoma of the prostate
in a 63-year-old patient who had taken colchicine daily for 25 years prior to lesion discovery. Failure to demonstrate metastasis was unexpected both because of lesion size (estimated volume 4.4 ml) as well as its histopathology (Gleason pattern 3S, grade 6). Colchicine may have inhibited metastasis of activated Ki-ras oncogenes during oncogenesis along neural microtubules in the area because of the known inhibitory effect of this drug on particle transport along the microtubule component of the cytoskeleton. Colchicine at therapeutic doses for gout may simultaneously inhibit metastasis of other types of malignancies in man.
...
PMID:Possible modification of metastasis from adenocarcinoma of the prostate by colchicine: a case report. 176 83
Although axial bone and cranial
metastases
are common in patients with prostatic carcinoma, temporal bone involvement is rare. We report 2 cases of
prostatic adenocarcinoma
with temporal bone metastasis and review the relevant literature. One case had a 3-year history of a prostatic carcinoma, whereas in the second case the temporal bone metastasis was the initial presentation. Awareness of the possibility of temporal bone involvement by prostate carcinoma and application of immunohistochemical studies will help to arrive at the correct diagnosis.
...
PMID:Temporal bone involvement by prostatic adenocarcinoma: report of two cases and review of the literature. 186 38
In order to evaluate the initial T stage and tumour grade as predictors of
metastatic disease
and prognosis in
adenocarcinoma of the prostate
, 963 patients were reviewed. Of the patients, 41% presented with
metastatic disease
. Stage T4 tumours were associated with a consistently poor prognosis, and 70% of such patients had demonstrable distant
metastases
. No patient with TOf local disease had
metastases
or died of prostate cancer during follow-up. The incidence of
metastases
was also low in stages T1 and T2. High tumour grade correlated strongly with more advanced disease. Using this information a more cost-effective approach to the staging of prostate carcinoma is proposed.
...
PMID:Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging. 190 62
Between 1970 and 1983, 273 patients underwent radical surgery (radical prostatectomy--261, radical cystoprostatectomy--12) for newly diagnosed
adenocarcinoma of the prostate
at Duke University Medical Center and received no adjuvant radiotherapy. A total of 46 patients developed local recurrence. Forty developed local relapse only and six developed simultaneous local and distant failure. The crude local relapse rate was 17% (46/273). The actuarial local failure rate at 5, 10, and 15 years was 12%, 32%, and 35%, respectively. Univariate and multivariate analyses were performed to identify factors predictive of local relapse after radical surgery. Possible prognostic factors analyzed were: age, type of biopsy, use of adjuvant hormonal therapy, histologic grade, histologic involvement of seminal vesicles, positive surgical margins, clinical stage, and elevated acid phosphatase. Factors identified as significant predictors of local relapse by univariate analysis were: poorly differentiated histology (p = 0.0001), seminal vesicle involvement (p = 0.0009), and positive surgical margins (p = 0.0001). An elevated preoperative acid phosphatase was of borderline significance (p = 0.06). On multivariate analysis, poorly differentiated histology (p = 0.0007), positive margins (p = 0.0015), and elevated acid phosphatase (p = 0.0273) were significant predictors of local failure. Seminal vesicle involvement was no longer a significant predictor of local failure. However, on subsequent univariate and multivariate analyses, seminal vesicle involvement was the only significant predictor for the development of distant
metastases
(p = 0.0019, multivariate). Thus, patients with poorly differentiated tumors, positive surgical margins, or elevated preoperative acid phosphatase are at high risk for local relapse after radical prostatectomy. These patients should be included in future clinical trials studying the role of adjuvant radiotherapy after radical prostatectomy, or offered adjuvant radiotherapy if they cannot or will not participate in such trials.
...
PMID:Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy. 163 48
Metastasis
of
adenocarcinoma of the prostate
to the medullary or central nervous system constitutes a worse prognosis. Surgical excision of the tumor permits a longer survival. Complete androgenic hormonal block affords temporary control of the disease.
...
PMID:[Cerebral metastasis of prostatic adenocarcinoma. Hormonal control and review of the literature]. 195 65
A 61-year-old black man presented with
metastases
to the right groin 5 years after 125iodine treatment for a well differentiated primary
prostatic adenocarcinoma
. Medium sized veins within and immediately adjacent to the neoplasm showed marked mural thickening due to hypertrophy and hyperplasia of the inner circular and outer longitudinal muscles. There was no histological evidence of radiation effect in the stroma or in the tumor cells. We could find no report in the literature of such changes associated with metastatic carcinoma.
...
PMID:Exaggerated venous mural hypertrophy in association with metastatic adenocarcinoma of the prostate. 198 79
Adenocarcinoma of the prostate is the second most common cancer of American males over age fifty. However, the reported instances of cerebral
metastases
have been exceedingly rare and are usually diagnosed at postmortem. This report describes an unusual case of brain metastasis from an occult
adenocarcinoma of the prostate
confirmed by craniotomy and tumor resection.
...
PMID:Magnetic resonance imaging diagnosis of an intracranial metastasis of adenocarcinoma of the prostate: case report. 199 94
Carcinoma of the prostate may present with
metastatic disease
many years after treatment. We present a patient with
adenocarcinoma of the prostate
, "cured" by radical perineal prostatectomy in 1962, with the first signs of
metastases
presenting in 1985. This emphasizes the importance of long-term follow-up of patients with prostate carcinoma.
...
PMID:Metastatic carcinoma of prostate 23 years after radical prostatectomy. 202 99
We report two cases of primary paraganglioma of the urinary bladder. Case 1. A 61-year-old man was hospitalized with the chief complaints of gross hematuria, dysuria and headache. The patient had a history of hypertension. Cystoscopy disclosed a nonpapillary, sessile tumor in the retrotrigonum of the bladder. An attack of paroxysmal hypertension was induced by bimanual palpation of the tumor, and paraganglioma was suspected. Partial cystectomy with staging pelvic lymphadenectomy was performed. Case 2. A 65-year-old man was hospitalized with the chief complaints of gross hematuria and urinary retention. The patient had no history of hypertension. Cystoscopy disclosed a nonpapillary tumor in the right lateral wall of the bladder. Transurethral resection was performed with no cardiovascular complication. Prostatic needle biopsy showed the histological evidence of
prostatic adenocarcinoma
. Radical retropubic prostatectomy with limited lymphadenectomy was performed. There was no histological evidence of lymph node involvement of paraganglioma or adenocarcinoma. The histological and biochemical examinations revealed a chromaffin positive, functioning and non-malignant tumor in Case 1, and a chromaffin negative, non-functioning and non-malignant tumor in Case 2. In total, 29 cases of primary paraganglioma of the urinary bladder have been so far reported in Japan. The tumor recurrence, multiple or
metastases
were recorded in 8 of 29 cases (27.6%), mainly in regional lymph node
metastases
. We recommend lymphadenectomy at the initial operation, irrespective of pathological finding of the primary paraganglioma of the urinary bladder.
...
PMID:[Primary paraganglioma of the urinary bladder: a report of two cases]. 223 62
Pelvic lymphadenectomy is the final staging procedure before institution of therapy for patients with clinically locally confined
adenocarcinoma of the prostate
, a normal acid phosphatase, and a bone scan free of
metastatic disease
. The pathologic information it provides cannot be accurately acquired at the present time by any other method. Extraperitoneal lymphadenectomy is associated with some morbidity intraoperatively and in the early postoperative period. We enumerate our results with 284 extraperitoneal lymphadenectomies.
...
PMID:Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. 231 85
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>